SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMULOGIC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Richardson who wrote (151)4/16/1997 3:06:00 PM
From: Xingbo Wang   of 305
 
Maybe I should have said that "I have been bothered by the fact that I am not yet fully convinced that the vaccine works because the vaccine appeared to be moderately effective in only one of two dosage regimens." This is in contrast to the words such as "strikingly positive" or "clearly positive", as seen in some other clinical trial results. It has not been proven conclusively (at least to me) that the vaccine works. That's the whole reason why the FDA required them to do another trial.

The Street welcomed the management shuffle at first, and we had a brief run from 5 1/2 to 7. Now part of the reason we are back to 4 is that the whole biotech sector is doing poorly. Biotech sector trades on market sentiment more than any other sector, since the majority of biotech companies have nothing that Wall Street can base value on (revenues, earnings, cash flow...). So until the market sentiment changes or something very postive happens to IMUL, we are stuck here at 4.

Regards,

Xingbo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News